PT3106874T - Método para a deteção de cancro - Google Patents

Método para a deteção de cancro

Info

Publication number
PT3106874T
PT3106874T PT161814298T PT16181429T PT3106874T PT 3106874 T PT3106874 T PT 3106874T PT 161814298 T PT161814298 T PT 161814298T PT 16181429 T PT16181429 T PT 16181429T PT 3106874 T PT3106874 T PT 3106874T
Authority
PT
Portugal
Prior art keywords
cancer detection
cancer
detection
Prior art date
Application number
PT161814298T
Other languages
English (en)
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of PT3106874T publication Critical patent/PT3106874T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4727Calcium binding proteins, e.g. calmodulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT161814298T 2007-10-25 2008-10-23 Método para a deteção de cancro PT3106874T (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2007277747 2007-10-25
JP2007277697 2007-10-25
JP2007279512 2007-10-26
JP2007279580 2007-10-26
JP2008254170 2008-09-30

Publications (1)

Publication Number Publication Date
PT3106874T true PT3106874T (pt) 2020-05-08

Family

ID=40579577

Family Applications (4)

Application Number Title Priority Date Filing Date
PT161814330T PT3106875T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT88423918T PT2207037T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT161814298T PT3106874T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT161814165T PT3106873T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT161814330T PT3106875T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro
PT88423918T PT2207037T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT161814165T PT3106873T (pt) 2007-10-25 2008-10-23 Método para a deteção de cancro

Country Status (11)

Country Link
US (1) US9249409B2 (pt)
EP (4) EP2207037B1 (pt)
JP (4) JP5439815B2 (pt)
KR (4) KR101633351B1 (pt)
CN (5) CN106093399B (pt)
AU (1) AU2008314929B2 (pt)
CA (4) CA3076717C (pt)
DK (4) DK3106875T3 (pt)
ES (4) ES2788152T3 (pt)
PT (4) PT3106875T (pt)
WO (1) WO2009054475A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2322221E (pt) 2008-08-05 2014-09-19 Toray Industries Composição farmacêutica para tratamento e prevenção de cancro
US11137401B2 (en) 2008-08-05 2021-10-05 Toray Industries, Inc. Method for detecting cancer using CAPRIN-1 as a marker
RU2603742C2 (ru) 2010-02-04 2016-11-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики рака
RU2445625C1 (ru) * 2011-01-11 2012-03-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития многоузловых поражений при лейомиоме матки
PT2740796T (pt) 2011-08-04 2017-07-26 Toray Industries Composição farmacêutica para o tratamento e/ou profilaxia de cancro
WO2013018886A1 (ja) 2011-08-04 2013-02-07 東レ株式会社 膵臓癌の治療及び/又は予防用医薬組成物
EP2741085B1 (en) 2011-08-04 2017-04-05 Toray Industries, Inc. Method for detecting pancreatic cancer
EP2818482B1 (en) 2012-02-21 2019-05-22 Toray Industries, Inc. Pharmaceutical composition for treatment of cancer
IN2014KN01715A (pt) 2012-02-21 2015-10-23 Toray Industries
PL2832365T3 (pl) 2012-03-30 2018-04-30 Toray Industries, Inc. Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi wątroby
EP2832366B1 (en) 2012-03-30 2017-11-08 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of gallbladder cancer
JP6244911B2 (ja) 2012-07-19 2017-12-13 東レ株式会社 癌の検出方法
ES2769831T3 (es) 2012-07-19 2020-06-29 Toray Industries Método para detectar cáncer
HUE042081T2 (hu) 2013-08-09 2019-06-28 Toray Industries Gyógyászati készítmény rák kezelésére és/vagy megelõzésére
JP5995117B2 (ja) * 2015-01-26 2016-09-21 国立大学法人 筑波大学 可溶型cd155タンパク質を用いた癌の検出方法
WO2019123392A1 (en) * 2017-12-20 2019-06-27 Herane Vives Andres Method for measuring average cortisol and glucose concentrations in earwax

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355623B2 (en) * 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
CA2425569A1 (en) * 2000-10-13 2002-04-18 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
EP1409504A2 (en) * 2001-03-29 2004-04-21 Incyte Genomics, Inc. Secretory molecules
US20030108963A1 (en) 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
US20030124579A1 (en) * 2001-09-05 2003-07-03 Eos Biotechnology, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20070237770A1 (en) * 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
US7279566B2 (en) * 2002-09-13 2007-10-09 University Of Massachusetts Centrosome proteins and uses thereof
JP2006517094A (ja) * 2002-10-22 2006-07-20 ヌベロ, インコーポレイテッド 新規核酸およびポリペプチド
CN1852974A (zh) * 2003-06-09 2006-10-25 密歇根大学董事会 用于治疗和诊断癌症的组合物和方法
BRPI0412725B8 (pt) * 2003-07-17 2021-07-27 Pacific Edge Biotechnology Ltd marcadores para detecção de câncer gástrico
US7807392B1 (en) * 2003-09-15 2010-10-05 Celera Corporation Lung disease targets and uses thereof
EP1892306A3 (en) 2003-10-06 2008-06-11 Bayer HealthCare AG Methods and kits for investigating cancer
CN1657537A (zh) * 2004-02-19 2005-08-24 中国人民解放军军事医学科学院放射医学研究所 一种中心体定位的新基因及其在医药领域中的应用
US20080199468A1 (en) * 2004-02-24 2008-08-21 Oncotherapy Science, Inc. Method For Diagnosing Colorectal Cancers
US7560233B2 (en) * 2004-06-16 2009-07-14 University Of Massachusetts Oxidative DNA damage protection
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CN104906597B (zh) * 2007-10-25 2018-07-10 东丽株式会社 免疫诱导剂

Also Published As

Publication number Publication date
EP3106875B1 (en) 2020-04-29
DK3106873T3 (da) 2019-09-23
JP5439815B2 (ja) 2014-03-12
DK3106875T3 (da) 2020-06-02
PT3106873T (pt) 2019-10-18
AU2008314929B2 (en) 2014-07-10
EP2207037A4 (en) 2011-03-16
JP5713037B2 (ja) 2015-05-07
EP3106874A1 (en) 2016-12-21
CA3076717C (en) 2023-01-03
US9249409B2 (en) 2016-02-02
JP5713035B2 (ja) 2015-05-07
CA3076845C (en) 2022-06-07
EP3106874B1 (en) 2020-04-01
CN106093398A (zh) 2016-11-09
CN106093399B (zh) 2019-01-25
CA2703356C (en) 2020-05-05
CA2703356A1 (en) 2009-04-30
ES2748390T3 (es) 2020-03-16
CA3076730C (en) 2022-06-21
CA3076845A1 (en) 2009-04-30
CN106093399A (zh) 2016-11-09
KR101633351B1 (ko) 2016-06-27
KR20150041807A (ko) 2015-04-17
CN106053833A (zh) 2016-10-26
JP2013101149A (ja) 2013-05-23
CN101836116A (zh) 2010-09-15
CA3076730A1 (en) 2009-04-30
KR20150041808A (ko) 2015-04-17
CN106093398B (zh) 2019-01-29
ES2788152T3 (es) 2020-10-20
CA3076717A1 (en) 2009-04-30
CN106053833B (zh) 2018-12-25
DK2207037T3 (en) 2016-12-19
CN106086177B (zh) 2021-09-10
EP3106873B1 (en) 2019-07-17
JPWO2009054475A1 (ja) 2011-03-10
KR101715666B1 (ko) 2017-03-13
CN106086177A (zh) 2016-11-09
US20100297646A1 (en) 2010-11-25
ES2798266T3 (es) 2020-12-10
ES2605646T3 (es) 2017-03-15
PT2207037T (pt) 2016-12-09
EP3106875A1 (en) 2016-12-21
KR20150041809A (ko) 2015-04-17
EP3106873A1 (en) 2016-12-21
JP2013101147A (ja) 2013-05-23
JP2013101148A (ja) 2013-05-23
PT3106875T (pt) 2020-06-22
JP5713036B2 (ja) 2015-05-07
WO2009054475A1 (ja) 2009-04-30
DK3106874T3 (da) 2020-06-02
EP2207037B1 (en) 2016-09-07
AU2008314929A1 (en) 2009-04-30
KR20100083768A (ko) 2010-07-22
KR101715661B1 (ko) 2017-03-13
EP2207037A1 (en) 2010-07-14

Similar Documents

Publication Publication Date Title
PT3106873T (pt) Método para a deteção de cancro
BRPI0815725A2 (pt) Métodos para detecção de oligonucleotídeos
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
BRPI0813284A2 (pt) Processos para a preparação de pirazóis
PL2325648T3 (pl) Sposób wykrywania nowotworów
BRPI0810767A2 (pt) Método para otimizar enlaces de campo próximo
BRPI0821129A2 (pt) Métodos para a inibição de cicatrização
FI20075721L (fi) Menetelmä pyrolysoinnin toteuttamiseksi
BRPI0817394A2 (pt) Método para processamento de pozzolans
FI20075465L (fi) Talteenottomenetelmä
BRPI0923266A2 (pt) metodo para recuperacao avancada de petroleo
BRPI0817667A2 (pt) Método de marcação
BRPI0819127A2 (pt) Método para cimentar.
BRPI0814706A2 (pt) Meios para remoção de compostos orgânicos
BRPI1011865A2 (pt) folha de entrada para a perfuração
BRPI0812741A2 (pt) Método para separação de glóbulos
BRPI0924013A2 (pt) método para o exame de câncer
BRPI0810416A2 (pt) Método de hidroformação
BRPI0818674A2 (pt) Método para produção de anticorpos
BRPI0819448A2 (pt) Método para transações seguras
EP2240886A4 (en) LIGHTNING DETECTION
PT2214358T (pt) Método para o mapeamento de túneis
DK2272538T3 (da) Fremgangsmåde til påvisning af blærecancer